The startup manufactures a medical device designed to protect the tongue during seizures by preventing injuries from biting and reducing hypersalivation, which can cause foaming at the mouth. This device enhances patient safety during neurological episodes by providing a structural and functional barrier.
Funding
$900K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Individuals experiencing seizures are at risk of severe tongue injuries from biting, as well as choking and aspiration due to excessive salivation. Traditional methods of intervention, such as placing foreign objects in the mouth, are often ineffective and can cause further harm.
Solution
NeuroVice has developed PATI (Protector Against Tongue Injury), a disposable oral device designed to mitigate the risks associated with seizures. PATI provides a structural barrier that prevents tongue biting and reduces oral trauma during a seizure. Its design promotes natural airflow and prevents saliva from collecting in the mouth, reducing the risk of choking. The device comes in a portable, single-use pouch and is available via prescription.
Target Audience
The primary target audience includes individuals with epilepsy or other seizure disorders, their caregivers, and medical professionals involved in their care.
Features
- Disposable, single-use design for convenient and hygienic application
- Structural barrier to prevent tongue biting and oral trauma
- Allows for natural airflow to facilitate breathing during a seizure
- Prevents saliva accumulation to reduce the risk of choking and aspiration
- Portable, tear-away packaging for easy access in emergency situations
- Available via prescription from a medical professional